PHARMA

Amrutanjan Health Care Ltd shares fall 1.01% as SEBI disclosure received for DSP Trustee & Others

By Dev Parmar •
The Exchange has received a disclosure under Regulation 29(2) of SEBIs Substantial Acquisition of Shares & Takeovers Regulations, 2011, from DSP Trustee Pvt Ltd and others regarding potential share...

Why did Amrutanjan Health Care Ltd-$ shares fall today?

Amrutanjan Health Care Ltd shares fell by 1.01% on Thursday, trading at ₹519.9 as of 04:08 PM. This decline indicates that investors were selling more shares than buying during the session, leading to a dip in the stock's value.

The movement is linked to a recent regulatory disclosure received by the exchange. As per the filing, the company has received information under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, from DSP Trustee Pvt Ltd & Others. In simple terms, this regulation requires major shareholders or potential acquirers to notify the company and the stock exchanges when their shareholding crosses certain specified thresholds. Such a disclosure typically signals a significant transaction, like a large investor buying or selling a substantial block of shares.

Market participants often react to such news as it can indicate shifts in the company's ownership structure. However, it's important to note that the filing itself is a procedural requirement and does not inherently provide insight into the company's fundamental business performance. The stock's dip today may be a short-term market reaction to this specific event.

What does Amrutanjan Health Care Ltd-$ do?

Based on the information available, the document does not contain specific details about Amrutanjan Health Care Ltd-$. The extract provided is empty, so no factual description of the company's business activities, sector, or products can be derived from it.

Consequently, there is no data within the given source to support writing about the company's operations or what it does. The response is limited to acknowledging the absence of substantive information in the provided extract.

Amrutanjan Health Care Ltd-$ Financials

In Crores
141
19
Dec 2025
150
16
Mar 2026
Revenue
Net Profit

Amrutanjan Health Care Ltd's revenue grew from ₹141.04 Crores in December 2025 to ₹149.77 Crores in March 2026, indicating a positive sales trend over the period. However, this top-line growth did not translate to the bottom line, as profit declined from ₹19.45 Crores to ₹16.19 Crores in the same timeframe. The financials thus show an increase in sales revenue coupled with a reduction in net profit.

Amrutanjan Health Care Ltd-$ Shareholding Pattern

Holdings
Promoter
46.52%
FIIs
2.44%
DIIs
12.29%
Public
38.72%

Promoter holding stands at 46.52% of the total share capital. Foreign Institutional Investors (FIIs) hold 2.44% stake in the company, while Domestic Institutional Investors (DIIs) hold 12.29%. Public shareholders hold the remaining 38.72% stake in Amrutanjan Health Care Ltd-$.

Amrutanjan Health Care Ltd-$ FAQs

Q: Why did Amrutanjan shares fall 1.01% today?

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee Pvt Ltd & Others. This corporate action caught investor attention, leading to increased trading activity in the stock.

Q: What is the shareholding pattern of Amrutanjan Health Care Ltd-$?

As per the latest data, promoters hold 46.52% stake in Amrutanjan Health Care Ltd-$, while FII holding stands at 2.44%. Domestic institutional investors hold 12.29%, and public shareholders account for 38.72% of the equity.

Q: What is the current stock price of Amrutanjan Health Care Ltd-$?

Amrutanjan Health Care Ltd-$ shares are currently trading at ₹519.9, recording a decline of 1.01% from the previous close.

Q: What is the market capitalization of Amrutanjan Health Care Ltd-$?

The company currently has a market capitalization of ₹1502.52 crore, reflecting its valuation in the Indian equity market.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. The stock prices mentioned are as of the time of writing. Dev Parmar and the publisher do not hold any positions in the stocks mentioned. Please consult a SEBI-registered financial advisor before making any investment decisions.